when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

by stage

Marketed
Phase 3
Phase 2
Phase 1
Preclinical

browse

Most catalysts
Recently active
All drugs →
Companies
Patent cliff

what

Trial readouts
PDUFA dates
Approvals
Earnings

when

Upcoming
Month grid
Recently passed

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News
Drugs
Calendar
Companies

Hubs

Topics
Patent cliff
Publications
Readouts

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

PLATINUM · news · pharmadog

← back to PLATINUM

News mentioning PLATINUM

43 stories

6dFDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinomafda press

7d6 potential blockbusters that could pave China’s path to 2030 ambitionsbiospace

14dGenmab's $8B Merus bet delivers as bispecific combo halves risk of death in phase 3fiercebiotech

15dGSK’s B7-H3 ADC drives 67% cancer risk reduction in Hansoh's phase 3 China trialfiercebiotech

16dESMO 2026: Merck’s Kelun-partnered ADC cuts death risk by over 30% in endometrial cancerbiospace

16dESMO 2026: Amgen’s Imdelltra slashes death risk by nearly 60% in small cell lung cancerbiospace

16dGenmab’s ADC beats survival expectations in Phase 3 ovarian cancer trialbiospace

20dESMO: Zentalis already dreaming of launch for WEE1 inhibitor after ‘great result’ in early-stage testfiercebiotech

20dESMO: Boehringer builds case for late-phase rival to Amgen’s Imdelltrafiercebiotech

20dESMO 2026: Merck’s Kelun-partnered ADC hits the ‘Goldilocks zone,’ VP saysbiospace

20dESMO: GSK cancer R&D chief says mo-rez data ‘reinforces our belief’ in ADC as phase 3 push ramps upfiercebiotech

21dThe 6 biggest crossover rounds in biopharma historybiospace

22dEpkinly data only one of Genmab's make-or-break readouts ahead of steep sales erosionbiospace

23dMerck/Moderna, Summit/Akeso and ADCs to headline ESMO 2026biospace

23dESMO: Lilly touts 79% ADC response rate in competitive ovarian cancer spacefiercebiotech

Oct 6, 26ArriVent’s phase 3 lung cancer trial flops, sinking stockfiercebiotech

Oct 5, 26Genmab details ovarian cancer data; Lilly's Jaypirca gets a label expansionendpoints

Oct 5, 26Genmab’s latest phase 2 data spur claim ADC is ‘clearly superior’ to AbbVie’s Elaherefiercebiotech

Sep 28, 26Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitorbiospace

Sep 28, 26Merck, Daiichi Sankyo retract accelerated approval request for lung cancer ADCbiospace

Sep 28, 26Merck, Daiichi pull lung cancer filing after FDA pushback deals another blow to $4B dealfiercebiotech

Sep 14, 26Summit, BioNTech, more headline WCLC with next-gen lung cancer drugsbiospace

Sep 11, 26Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancerfiercebiotech

Sep 11, 26STAT+: Cancer drug shortages keep disrupting patient carestat

Sep 11, 26Boycott launched against American Diabetes Association includes journalstat

Sep 11, 26STAT+: An AI tool aims to catch harder-to-detect heart attacks in EKGsstat

Sep 11, 26GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merckfiercebiotech

Sep 10, 26Platinum-based chemotherapy in childhood causes mutations that age the liverstat

Sep 3, 26RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancerbiospace

Aug 13, 26Cullinan tees up J&J fight—and $100M payday—as Taiho-partnered drug hits phase 3 cancer goalfiercebiotech

← prevpage 1 of 2next →